Reported Earlier, HUTCHMED To Present New And Updated Clinical Data On Fruquintinib, Savolitinib And Surufatinib At ESMO Congress 2025 In Berlin
Benzinga Newsdesk 1 year ago
News
new and updated data from several studies of compounds discovered by HUTCHMED will be presented at the European Society for Medical Oncology ("ESMO") Congress 2025, taking place on October 17-21, 2025 in Berlin, Germany.
new and updated data from several studies of compounds discovered by HUTCHMED will be presented at the European Society for Medical Oncology ("ESMO") Congress 2025, taking place on October 17-21, 2025 in Berlin, Germany.